Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › PA › ALLENTOWN › ST LUKE'S HOSPITAL

ST LUKE'S HOSPITAL

NPI: 1952399933 · ALLENTOWN, PA 18102 · General Acute Care Hospital · NPI assigned 10/12/2005

$6.98M
Total Medicaid Paid
157,165
Total Claims
145,066
Beneficiaries
188
Codes Billed
2018-01
First Month
2024-01
Last Month

Provider Details

Authorized OfficialLICHTENWALNER, THOMAS (SENIOR VP FINANCE)
NPI Enumeration Date10/12/2005

Related Entities

Other providers sharing the same authorized official: LICHTENWALNER, THOMAS

ProviderCityStateTotal Paid
ST LUKE'S HOSPITAL ALLENTOWN PA $4.97M
THE CARBON SCHUYLKILL COMMUNITY HOSPITAL, INC. TAMAQUA PA $2.00M
ST LUKE'S HOSPITAL LEHIGHTON PA $1.16M
THE CARBON-SCHUYLKILL COMMUNITY HOSPITAL, INC. LANSFORD PA $758K
THE CARBON-SCHUYLKILL COMMUNITY HOSPITAL, INC. RINGTOWN PA $393K
GSLPG, INC ORWIGSBURG PA $31K
ST. LUKE'S HOSPITAL PALMERTON PA $607.60

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 602 $31K
2019 200 $18K
2020 20,143 $819K
2021 86,522 $3.76M
2022 24,695 $1.26M
2023 23,958 $1.04M
2024 1,045 $48K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 18,402 17,735 $2.18M
99284 Emergency department visit for the evaluation and management, high severity 10,099 9,728 $1.48M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 3,298 3,129 $633K
G0378 Hospital observation service, per hour 380 360 $356K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 2,033 2,017 $215K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2,195 2,106 $177K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3,847 3,764 $176K
74177 Computed tomography, abdomen and pelvis; with contrast material 734 704 $131K
80050 General health panel 2,506 2,479 $113K
80053 Comprehensive metabolic panel 10,110 9,635 $105K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2,762 2,706 $96K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2,021 875 $74K
77067 Screening mammography, bilateral, including computer-aided detection 790 778 $68K
80061 Lipid panel 4,733 4,708 $65K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,005 955 $57K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 10,122 9,654 $54K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 1,548 1,539 $44K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 4,855 4,623 $41K
70450 Computed tomography, head or brain; without contrast material 535 529 $38K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1,304 1,297 $35K
86803 1,653 1,644 $32K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 109 106 $30K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 370 365 $29K
71275 Computed tomographic angiography, chest, with contrast material 137 133 $28K
J1756 Injection, iron sucrose, 1 mg 2,109 862 $27K
74176 Computed tomography, abdomen and pelvis; without contrast material 271 262 $26K
84443 Thyroid stimulating hormone (TSH) 1,122 1,108 $25K
X0616 138 136 $25K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1,034 1,014 $24K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1,031 1,011 $24K
78815 Positron emission tomography (PET) for limited area imaging 29 28 $21K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 443 437 $21K
77066 Tomosynthesis, mammo 222 218 $18K
77063 Screening digital breast tomosynthesis, bilateral 729 717 $16K
76642 417 406 $16K
80081 168 168 $15K
83036 Hemoglobin; glycosylated (A1C) 2,001 1,984 $14K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,269 898 $14K
82728 963 956 $12K
80048 Basic metabolic panel (calcium, ionized) 1,337 1,251 $12K
81001 3,900 3,784 $11K
83880 353 345 $11K
71046 Radiologic examination, chest; 2 views 928 905 $11K
83690 2,357 2,274 $10K
83735 1,503 1,405 $10K
82607 987 984 $10K
87631 74 74 $10K
87340 671 668 $10K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 133 89 $10K
86480 124 124 $9K
85027 1,284 1,196 $9K
76705 Ultrasound, abdominal, real time with image documentation; limited 280 274 $9K
73630 868 694 $8K
83540 856 850 $7K
71045 Radiologic examination, chest; single view 1,412 1,358 $7K
84484 849 775 $7K
84439 828 820 $7K
84153 269 266 $7K
84702 405 338 $7K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 172 161 $6K
72125 Computed tomography, cervical spine; without contrast material 79 78 $6K
82784 252 250 $6K
71250 90 87 $6K
82570 802 790 $6K
76536 115 114 $6K
87086 Culture, bacterial; quantitative colony count, urine 743 724 $6K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 318 314 $6K
86003 38 38 $5K
82043 634 629 $5K
83970 121 120 $5K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 27 27 $5K
J3490 Unclassified drugs 496 226 $5K
90715 205 200 $4K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 78 72 $4K
72110 200 198 $4K
99281 Emergency department visit for the evaluation and management, self-limited or minor 105 101 $4K
83550 831 826 $4K
73610 304 297 $4K
76770 101 100 $4K
84403 142 142 $4K
86592 924 918 $4K
D1110 Prophylaxis - adult 117 116 $4K
73030 319 290 $4K
71260 Computed tomography, thorax, diagnostic; with contrast material 58 58 $4K
85610 1,018 903 $4K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 75 75 $4K
85007 953 875 $4K
86038 220 219 $3K
87040 181 168 $3K
73564 225 212 $3K
73130 342 282 $3K
86618 124 124 $3K
85730 503 488 $3K
76700 Ultrasound, abdominal, real time with image documentation; complete 56 56 $3K
73562 208 162 $3K
85379 306 292 $3K
82746 308 308 $3K
96367 156 88 $3K
86780 194 193 $3K
82550 327 319 $2K
77065 Tomosynthesis, mammo 41 40 $2K
86800 122 122 $2K
86140 721 712 $2K
83605 300 279 $2K
80074 38 36 $2K
93017 57 55 $2K
83020 170 170 $2K
85652 616 611 $2K
93226 43 43 $2K
J7030 Infusion, normal saline solution , 1000 cc 896 795 $2K
70486 24 24 $2K
D0120 Periodic oral evaluation - established patient 91 91 $2K
77080 40 39 $2K
36415 Collection of venous blood by venipuncture 788 679 $2K
84550 247 235 $2K
73502 88 82 $1K
86704 94 94 $1K
84402 51 51 $1K
82950 199 199 $1K
81003 477 468 $1K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 76 73 $1K
83615 182 170 $1K
87077 177 172 $1K
72100 85 84 $1K
87186 155 152 $1K
73110 130 120 $1K
86850 152 146 $1K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 12 12 $1K
82948 666 605 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg 4,792 4,478 $1K
83001 62 61 $1K
84100 189 162 $1K
D2391 Resin-based composite - one surface, posterior, primary or permanent 24 16 $1K
86430 159 159 $1K
86255 53 53 $1K
84146 39 39 $997.44
86376 124 124 $993.83
J2270 Injection, morphine sulfate, up to 10 mg 529 484 $898.44
80076 99 83 $868.75
93225 43 43 $838.01
86901 205 198 $816.74
86900 205 198 $806.94
84165 55 54 $793.12
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 25 25 $765.21
86706 58 58 $745.66
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 1,333 753 $606.72
83655 55 55 $580.00
84703 47 47 $523.21
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,950 1,489 $499.53
88305 Level IV - Surgical pathology, gross and microscopic examination 54 53 $460.24
83002 24 24 $455.60
86200 28 28 $451.40
86705 27 27 $443.31
84156 93 89 $404.51
82785 26 26 $399.00
82805 13 12 $378.88
J2405 Injection, ondansetron hydrochloride, per 1 mg 3,102 2,578 $371.56
J7050 Infusion, normal saline solution, 250 cc 870 223 $367.74
74018 30 30 $342.92
72050 14 14 $338.80
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 59 56 $329.58
J2765 Injection, metoclopramide hcl, up to 10 mg 671 633 $317.48
J1200 Injection, diphenhydramine hcl, up to 50 mg 1,196 1,015 $294.36
84145 19 17 $293.16
82105 13 13 $280.00
82553 27 26 $272.20
72072 13 13 $256.60
J2704 Injection, propofol, 10 mg 1,406 733 $245.24
73590 13 12 $216.80
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 16 12 $198.00
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 22 12 $184.55
OP250 80 60 $160.49
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 280 265 $131.82
D0220 Intraoral - periapical first radiographic image 13 12 $95.55
J2060 Injection, lorazepam, 2 mg 234 204 $92.07
82248 13 12 $89.25
J0696 Injection, ceftriaxone sodium, per 250 mg 119 117 $57.76
82077 86 83 $42.12
J3010 Injection, fentanyl citrate, 0.1 mg 946 641 $37.63
81025 90 82 $24.00
J0690 Injection, cefazolin sodium, 500 mg 465 326 $19.56
J3475 Injection, magnesium sulfate, per 500 mg 14 14 $18.48
J2250 Injection, midazolam hydrochloride, per 1 mg 604 498 $3.17
J1170 Injection, hydromorphone, up to 4 mg 19 13 $0.00
A9270 Non-covered item or service 14 13 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 134 116 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 71 65 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 84 73 $0.00